Discover the latest 8-K report from Applied DNA Sciences, Inc. detailing significant corporate events as of February 14, 2025. Stay informed on stock performance and company developments.
Discover critical updates from Applied DNA Sciences, Inc. in their 8-K filing as of February 13, 2025. Essential insights for investors in the health sciences sector.
Explore Applied DNA Sciences, Inc.'s Q4 2023 financial results, highlighting revenue drops, a net loss, workforce reduction, and strategic shifts. Stock recommendation: Hold.
Dive into Applied DNA Sciences, Inc.'s 8-K report filed on January 13, 2025, detailing significant corporate events. Essential reading for APDN investors!
Discover critical updates from Applied DNA Sciences, Inc. in their 8-K report, revealing essential corporate and stock details as of December 17, 2024. Ticker: APDN.
Explore Applied DNA Sciences' 2024 financial results, revealing a net loss of $7M, declining revenues, and strategic shifts. Investment recommendation: Hold.